Hans Keirstead, Ph.D., spoke at the “Spotlight on Huntington’s Disease,” an educational event presented at the CIRM Governing Board meeting on December 12, 2007. Keirstead described strategies for using human embryonic stem cells to better understand Huntington’s disease. He also explained the importance of generating highly purified human stem cell lines in a FDA-compliant manner that is scalable for future clinical use. Keirstead is co-director of the Sue and Bill Gross Stem Cell Research Center and associate professor of anatomy and neurobiology at the University of California, Irvine.
Dr. Keirstead was introduced by Oswald Steward, Ph.D. Dr. Stewart is a member of the CIRM Governing Board and is chair and director of the Reeve-Irvine Research Center at the University of California, Irvine.